Literature DB >> 5040633

Partial suppression of experimental allergic encephalomyelitis with heparin.

E Chelmicka-Szorc, B G Arnason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5040633     DOI： 10.1001/archneur.1972.00490140057009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  6 in total

1.  Heparin affects the induction of regulatory T cells independent of anti-coagulant activity and suppresses allogeneic immune responses.

Authors:  Y Kashiwakura; H Kojima; Y Kanno; M Hashiguchi; T Kobata
Journal:  Clin Exp Immunol       Date:  2020-07-15       Impact factor: 4.330

2.  Heparin attenuates low-dose streptozotocin-induced immune diabetes in mice and inhibits the beta-cell binding of T-splenocytes in vitro.

Authors:  P Saï; S Pogu; M Ouary
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

3.  Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.

Authors:  Norah G Verbout; Xiaolin Yu; Laura D Healy; Kevin G Phillips; Erik I Tucker; András Gruber; Owen J T McCarty; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

4.  Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.

Authors:  O Lider; E Baharav; Y A Mekori; T Miller; Y Naparstek; I Vlodavsky; I R Cohen
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 5.  A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis.

Authors:  Domenico Plantone; Matilde Inglese; Marco Salvetti; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2019-01-14       Impact factor: 4.003

6.  Menstrual blood-derived mesenchymal stromal cells efficiently ameliorate experimental autoimmune encephalomyelitis by inhibiting T cell activation in mice.

Authors:  Yonghai Li; Haiyao Gao; Tobias M Brunner; Xiaoxi Hu; Yushan Yan; Yanli Liu; Liang Qiao; Peihua Wu; Meng Li; Qing Liu; Fen Yang; Juntang Lin; Max Löhning; Ping Shen
Journal:  Stem Cell Res Ther       Date:  2022-04-11       Impact factor: 6.832
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.